NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Thursday, March 5, 2015
Odds of Pirfenidone Approval in US
Based on the Japanese and US data, should we expect FDA to approve the drug for use in the USA fir people with IPF?
The FDA is currently reviewing the new drug application materials for pirfenidone and it is expected that they will render a decision on whether or not to approve it sometime in May 2009
James N Allen, Jr, MD
Clinical Professor of Pulmonary, Allergy, Critical Care & Sleep Medicine
College of Medicine
The Ohio State University